VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 634 filers reported holding VANECK VECTORS ETF TR in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,512,288 | +8.7% | 56,198 | +21.7% | 0.01% | +14.3% |
| Q2 2023 | $1,390,871 | -44.4% | 46,193 | -40.3% | 0.01% | -50.0% |
| Q1 2023 | $2,501,755 | +121.8% | 77,334 | +96.5% | 0.01% | +27.3% |
| Q4 2022 | $1,127,714 | -38.9% | 39,348 | -48.6% | 0.01% | -50.0% |
| Q3 2022 | $1,845,000 | +28.1% | 76,482 | +45.4% | 0.02% | +37.5% |
| Q2 2022 | $1,440,000 | -41.2% | 52,600 | -17.6% | 0.02% | -23.8% |
| Q1 2022 | $2,450,000 | -7.7% | 63,873 | -22.9% | 0.02% | -4.5% |
| Q4 2021 | $2,654,000 | +15.6% | 82,859 | +6.4% | 0.02% | +10.0% |
| Q3 2021 | $2,295,000 | +6.7% | 77,859 | +23.0% | 0.02% | +5.3% |
| Q2 2021 | $2,151,000 | -20.8% | 63,300 | -24.3% | 0.02% | -5.0% |
| Q1 2021 | $2,717,000 | -0.0% | 83,600 | +10.8% | 0.02% | +122.2% |
| Q4 2020 | $2,718,000 | – | 75,466 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |